CCL2 and neuroblastoma: In this study, we demonstrate that anti-CCL2 antibody suppresses in vitro monocyte and neuroblastoma migration to CCL2, and when combined with chemotherapy, improves survival in our tumor resection mouse model of neuroblastoma.